2015年-世界发展银行全球_Zambias_HIV_Response___Prioritised_and_Strategic_Allocation_of_HIV_Resources_for_Impact_and_Sustainability_121页_4mb

Summary of Zambia's HIV Response: Prioritised and Strategic Allocation of HIV Resources for Impact and Sustainability

Core Content

This report presents findings from an HIV allocative efficiency study conducted for the Government of Zambia by the World Bank and the University of New South Wales. It focuses on the strategic allocation of HIV resources to maximise impact and ensure sustainability, using the Optima mathematical model to simulate HIV transmission, disease progression, and the cost-effectiveness of various interventions.

Main Findings

HIV Epidemic Trends

• Zambia has a high HIV prevalence (14.3% among adults, per ZDHS 2007) and low male circumcision rates.
• Both Optima and Spectrum models predict a slow decline in HIV prevalence, with approximately 60,000 new infections per year projected until 2030.
• The number of mother-to-child transmissions (MTCT) has decreased significantly, from 25,000 in 2000 to 4,000 in 2013, representing an 85% reduction.
• Female sex workers (FSW) and men who have sex with men (MSM) have high HIV incidence rates (4.0% and 2.5%, respectively), but recent data is lacking.

HIV Financing and Implementation

• In 2012, Zambia's per capita health expenditure was US$96, and total HIV spending was approximately US$283 million, which was 7% of overall government spending.
• 93% of HIV funding came from external sources, with PEPFAR accounting for a large share (48% of total HIV spending in 2012).
• ART spending increased from US$23 million in 2005 to US$125 million in 2012, while VMMC and PMTCT programmes also saw growth.
• HIV counselling and testing (HCT) services reached 2.066 million adults in 2013, with more women than men using these services.
• The PMTCT programme has been successful, reducing MTCT from 24% in 2009 to 12% in 2012.
• Unprotected sexual intercourse remains a challenge, contributing to a high burden of curable STIs (about 10% of outpatient visits).

Key Programmes and Their Roles

• ART (Antiretroviral Therapy):

  • As of 2013, 580,118 people were on ART (81.9% coverage).
  • ART has reduced adult and infant AIDS death rates significantly.
  • ART is the most impactful programme in the short term (until 2030) for reducing HIV incidence and AIDS deaths.

• PMTCT (Prevention of Mother-to-Child Transmission):

  • PMTCT has contributed to a major reduction in MTCT.
  • It is supported by high ANC service uptake (96% in 2013-14).

• VMMC (Voluntary Medical Male Circumcision):

  • VMMC coverage reached 33% by 2013, far below the 80% target.
  • VMMC is a key prevention intervention, especially for men, and is expected to have long-term impact on reducing HIV incidence.
  • It is more impactful in a 30-year time horizon (2014–2044) than in the short term.

• HCT (HIV Counselling and Testing):

  • HCT is essential for identifying PLHIV and supporting ART expansion.
  • It is not a priority for reallocation in the short term but remains important for long-term impact.

• FSW and MSM Programmes:

  • These groups are high-risk and require targeted interventions.
  • Despite their importance, they are not prioritised in the short term due to their small population size.
  • They are critical for health service promotion and human rights support.

Resource Allocation and Efficiency

• Optimal Allocation Strategy:

  • With less than 70% of current funding, ART and PMTCT should be prioritised.
  • With 70–100% of current funding, PMTCT should be scaled up, and ART and HCT should be expanded.
  • With more than 100% of current funding, VMMC and FSW prevention programmes should be introduced.
  • With more than 160% of current funding, adult BCC and condom programmes should be scaled up.
  • Youth programmes become a priority only at more than 200% of current funding.

• Efficiency Gains:

  • The model suggests that efficiency gains can be achieved through better management and administration of HIV programmes.
  • Indirect costs and critical enablers account for about 30% of total HIV spending.
  • ART patient volumes could increase by 117% if more resources are allocated, with lower marginal costs for additional patients.

Financial Commitments

• Moderate Targets (by 2030):

  • Require 1.4 times current HIV spending.
  • Could avert 220,000 infections, 60,000 deaths, and 35,000 MTCT cases.

• Ambitious Targets (by 2030):

  • Require 2.5 times current HIV spending.
  • Could avert 460,000 infections, 104,000 deaths, and 35,000 MTCT cases.

• Long-term Financial Commitments:

  • Annual costs for meeting moderate targets: US$600 million.
  • Annual costs for meeting ambitious targets: Over US$1 billion.
  • PEPFAR and other external donors play a significant role in funding these programmes.

Conclusion

• ART, PMTCT, HCT, and VMMC are the core programmes for a high-impact HIV response.
• VMMC is more impactful over a longer time horizon, while ART is crucial in the short term.
• FSW and MSM programmes are important for targeting high-risk populations, even though they are not a priority in the short term.
• Sustainability is a major concern, with 93% of HIV funding coming from external sources.
• Strategic prioritisation and efficient resource allocation are essential for reducing HIV incidence and AIDS deaths while maintaining financial sustainability.

Recommendations

• Continue scaling up ART and PMTCT to maintain progress in reducing AIDS deaths and MTCT.
• Expand VMMC and FSW prevention programmes for long-term impact.
• Improve HCT and BCC to identify more PLHIV and promote prevention.
• Enhance domestic funding and reduce reliance on external assistance.
• Address legal and human rights barriers to improve access to HIV services for key populations.